XML 45 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions - Schedule of Unaudited Pro Forma Results of Operations (Detail) (Allos Therapeutics, Inc. [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2012
Allos Therapeutics, Inc. [Member]
   
Business Acquisition [Line Items]    
Total revenues $ 82,174 $ 153,367
Income from continuing operations 19,758 30,860
Net income $ 13,259 $ 47,364
Basic net income per share $ 0.23 $ 0.81
Diluted net income per share $ 0.21 $ 0.74